HIG
68
-7
EQIX
73
-2
SLG
59
-4
NKE
42
2
JNPR
47
-3
WAT
61
2
CSX
64
-3
A
41
2
SCHW
62
-3
KLAC
59
2
O
20
-8
EMC
59
6
EQR
53
-6
WDC
63
2
BRK.B
43
-2
CCI
33
-3
LMT
30
-2
WYNN
33
-9
DVA
71
-4
ACN
50
-6
HIG
68
-7
EQIX
73
-2
SLG
59
-4
NKE
42
2
JNPR
47
-3
WAT
61
2
CSX
64
-3
A
41
2
SCHW
62
-3
KLAC
59
2
O
20
-8
EMC
59
6
EQR
53
-6
WDC
63
2
BRK.B
43
-2
CCI
33
-3
LMT
30
-2
WYNN
33
-9
DVA
71
-4
ACN
50
-6
Financhill
Back

Dianthus Therapeutics Quote, Financials, Valuation and Earnings

Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

DNTH
Dianthus Therapeutics

Last Price:
25.42
Seasonality Move:
19.62%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Dianthus Therapeutics Price Quote

$25.42
-0.28 (-1.09%)
(Updated: December 3, 2024 at 1:10 PM ET)

Dianthus Therapeutics Key Stats

Sell
37
Dianthus Therapeutics (DNTH) is a Sell
Day range:
$23.62 - $25.89
52-week range:
$6.58 - $33.77
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
130.45
P/B ratio:
2.25%
Volume:
309.4K
Avg. volume:
272.5K
1-year change:
128.04%
Market cap:
$760.6M
Revenue:
$2.8M
EPS:
$-2.5

How Much Does Dianthus Therapeutics Make?

Is Dianthus Therapeutics Growing As A Company?

  • What Is Dianthus Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.35%
  • What Is Dianthus Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Dianthus Therapeutics Stock Price Performance

What Is Dianthus Therapeutics 52-Week High & Low?

Dianthus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Dianthus Therapeutics?

Is Dianthus Therapeutics Cash Flow Positive?

  • What Is DNTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$62.6M
  • What Is Dianthus Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $211.1M
  • What Is Dianthus Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$271.9M

Dianthus Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    DNTH return on invested capital is -23.69%
  • What Is Dianthus Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -22.7%
  • What Is DNTH Return On Equity?
    ROE is a measure of profitability and is -23.69%

Dianthus Therapeutics Earnings Date & Stock Price

Dianthus Therapeutics Competitors

Dianthus Therapeutics Dividend Yield

Dianthus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 135.07% 276.8%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 51.80
Upside from Last Price: 101.56%

Major Shareholders

  • How many DNTH shares are owned by institutional investors?
    40.3M DNTH shares are owned by institutional investors
  • How many DNTH shares are owned by insiders?
    4K DNTH shares are owned by insiders